CN Patent
CN101820859B — 制备包含枸橼酸、氧化镁、碳酸氢钾和匹可硫酸钠的药物产品的方法,包含通过该方法获得的细粒的药物组合物以及中间体
Assigned to Huiling International Pharmaceutical Switzerland Co ltd · Expires 2013-05-01 · 13y expired
What this patent protects
一种制备药物组合物的方法,所述药物组合物包含枸橼酸、氧化镁、碳酸氢钾和匹可硫酸钠以及任选的糖精钠和/或甜橙香精的均匀的或基本上均匀的混合物;产物,中间产物及其应用。
USPTO Abstract
一种制备药物组合物的方法,所述药物组合物包含枸橼酸、氧化镁、碳酸氢钾和匹可硫酸钠以及任选的糖精钠和/或甜橙香精的均匀的或基本上均匀的混合物;产物,中间产物及其应用。
Drugs covered by this patent
- Renacidin (CITRIC ACID) · Baxter
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.